EM2007C "Primary Aldosteronism – Diagnostic Dilemmas and Future Directions" (IM GR-071020)
Despite being the most common cause of secondary hypertension, primary aldosteronism (PA) is under recognized and underdiagnosed. Untreated, PA can lead to significant cardiac, cerebrovascular, and renal complications. The purpose of this session is to familiarize an internal medicine audience - most of whom deal with hypertension and/or its end organ effects - with the recognition and management of PA. Pitfalls regarding the diagnosis of PA will be discussed as well as future directions in PA management.
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
At the conclusion of this activity, the participant should be able to:
- Screen pts for primary aldosteronism (PA) and identify pitfalls to the diagnosis of PA.
- Recognize upcoming modalities to ease the burden of PA diagnosis.
- Be familiar with the management options (medical vs surgical) for PA.
Sasan Mirfakhraee, M.D.
Assistant Professor, Department of Internal Medicine
Division of Endocrinology
Program Director, Endocrinology and Metabolism Fellowship Program
- 1.00 AMA